Interpretation of the Hydrogen and Helium Spectra.

J. C. Slater

DOI: https://doi.org/10.1073/PNAS.11.12.732

1925-12-01

Abstract:

What problem does this paper attempt to address?

Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation

Madhu Kanchrana,Rama Krishna Gamidi,Jyothi Kumari,Dharmarajan Sriram,Srinivas Basavoju

DOI: https://doi.org/10.1007/s11030-023-10790-9

2024-01-24

Molecular Diversity

Abstract:The development of anti-tuberculosis (anti-TB) drugs has become a challenging task in medicinal chemistry. This is because Mycobacterium tuberculosis (TB), the pathogen that causes tuberculosis, has an increasing number of drug-resistant strains, and existing medication therapies are not very effective. This resistance significantly demands new anti-TB drug profiles. Here, we present the design and synthesis of a number of hybrid compounds with previously known anti-mycobacterial moieties attached to quinoxaline, quinoline, tetrazole, and 1,2,4-oxadiazole scaffolds. A convenient ultrasound methodology was employed to attain spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition of quinoxaline Schiff bases and aryl nitrile oxides at room temperature. This approach avoids standard heating and column chromatography while producing high yields and shorter reaction times. The target compounds 3a-p were well-characterized, and their in vitro anti-mycobacterial activity (anti-TB) was evaluated. Among the screened compounds, 3i displayed promising activity against the Mycobacterium tuberculosis cell line H37Rv, with an MIC99 value of 0.78 μg/mL. However, three compounds ( 3f , 3h , and 3o ) exhibited potent activity with MIC99 values of 6.25 μg/mL. To further understand the binding interactions, the synthesized compounds were docked against the tuberculosis protein 5OEQ using in silico molecular docking. Moreover, the most active compounds were additionally tested for their cytotoxicity against the RAW 264.7 cell line, and the cytotoxicity of compounds 3f , 3h , 3i , and 3o was 27.3, 28.9, 26.4, and 30.2 μg/mL, respectively. These results revealed that the compounds 3f , 3h , 3i , and 3o were less harmful to humans. Furthermore, the synthesized compounds were tested for ADME qualities, and the results suggest that this series is useful for producing innovative and potent anti-tubercular medicines in the future.

chemistry, multidisciplinary, medicinal, applied
Design, synthesis, characterization, and biological evaluation of novel pyrazine-1,3,4-oxadiazole/[1,2,4] triazolo[3,4-b][1,3,4]thiadiazine hybrids as potent antimycobacterial agents

Shiva kumar,P Dinesha,D Udayakumar,Varsha Prakash Shetty,Vijaya Kumar Deekshit

DOI: https://doi.org/10.1016/j.molstruc.2024.137657

IF: 3.841

2024-01-31

Journal of Molecular Structure

Abstract:In this study, we present novel pyrazine-1,3,4-oxadiazole hybrids (T1-T9) and [1,2,4]triazolo[3,4- b ][1,3,4]thiadiazine derivatives (T10-T18), which possess remarkable antimicrobial activity. These compounds have been meticulously scrutinized for their efficacy in combatting the M. tuberculosis H37Rv strain. Three compounds T7, T8, and T17 showed promising antitubercular activity with MIC of 1.56 μg/mL. The target compounds are also evaluated for their antibacterial activity against S. aureus, S. mutans, E. coli, and S. Typhi, and antifungal activity against A. niger. Most of the compounds showed significant antibacterial and antifungal activity. All the active compounds exhibited very low toxicity and none of the active compounds were toxic to the normal cells. To deepen our understanding of these compounds, an in-silico ADME, and molecular docking analysis against the DprE1 enzyme were conducted, followed by DFT studies to shed some light on their electronic properties, and enhance our grasp of their pharmacological potential.

chemistry, physical
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis

Pran Kishore Deb,Nizar A. Al-Shar’i,Katharigatta N. Venugopala,Melendhran Pillay,Pobitra Borah

DOI: https://doi.org/10.1080/14756366.2021.1900162

2021-01-01

Journal of Enzyme Inhibition and Medicinal Chemistry

Abstract:The alarming increase in multi- and extensively drug-resistant (MDR and XDR) strains of Mycobacterium tuberculosis (MTB) has triggered the scientific community to search for novel, effective, and safer therapeutics. To this end, a series of 3,5-disubstituted-1,2,4-oxadiazole derivatives (3a–3i) were tested against H37Rv, MDR and XDR strains of MTB. Of which, compound 3a with para-trifluorophenyl substituted oxadiazole showed excellent activity against the susceptible H37Rv and MDR-MTB strain with a MIC values of 8 and 16 µg/ml, respectively.To understand the mechanism of action of these compounds (3a–3i) and identify their putative drug target, molecular docking and dynamics studies were employed against a panel of 20 mycobacterial enzymes reported to be essential for mycobacterial growth and survival. These computational studies revealed polyketide synthase (Pks13) enzyme as the putative target. Moreover, in silico ADMET predictions showed satisfactory properties for these compounds, collectively, making them, particularly compound 3a, promising leads worthy of further optimisation.

biochemistry & molecular biology,chemistry, medicinal
Synthesis, Characterization, Antimicrobial, Anti-tubercular, Antioxidant Activities and Docking Simulations of Derivatives of 2-(pyridin-3-yl)-1Hbenzo[ d]imidazole and 1,3,4-Oxadiazole Analogy

Shipra Bhati,Vijay Kumar,Simranjeet Singh,Joginder Singh

DOI: https://doi.org/10.2174/1570180816666191122105313

2020-07-29

Abstract:Background: Antimicrobial Resistance (AMR) and Tuberculosis (TB) are global concern. According to the WHO fact sheet on tuberculosis, in 2017, 10 million people fell ill with TB, and 1.6 million including 230,000 children died from the disease. There is a critical need of design and development of novel chemotherapeutic agents to combat the emergence and increasing prevalence of resistant pathogens. In the present study, a new series of 1,3,4-oxadiazoles incorporating benzimidazole and pyridine scaffolds in a single molecular framework has been reported. Methods: The structures of the synthesized derivatives (4a to 4e) were assigned by IR, NMR and mass spectral techniques. The hybrid compounds were evaluated for their antimicrobial, antitubercular and antioxidant activities. In addition, docking simulations were performed to study ligand-protein interactions and to determine the probable binding conformations. Results: Molecule 4a has shown anti-tubular activities with MIC 1.6 μg/ml. As compared to ascorbic acid activities (IC50 = 62.91 μg/ml), molecule 4e exhibited better antioxidant activities (IC50 = 24.85 μg/ml). Also, molecule 4e has shown significant antimicrobial activities. Conclusion: The synthesized derivatives from 4a to 4e have exhibited various medicinal activities and could be emerged as lead compounds and further explored as potential therapeutic agents.

chemistry, medicinal
Development and Evaluation of New Oxindole Derivatives as Potential Anti-tubercular Agents

Vani Madhuri Velavalapalli,G Shiva Kumar,Naresh Kumar Katari,Rambabu Gundla

DOI: https://doi.org/10.1016/j.molstruc.2024.137649

IF: 3.841

2024-02-01

Journal of Molecular Structure

Abstract:Tuberculosis (TB), which affects the lungs and other parts of the body, claims the lives of around 3 million people. Indolin-2-one derivatives were identified as a novel anti-tubercular series from Microplate Alamar Blue Assay (MABA) method, along with its synthesis, characterisation, molecular docking, and molecular dynamic simulations. The enzyme decaprenylphosphoryl-β-D-ribose 20-oxidase (DprE1) demonstrated high binding interaction energies associated with these compounds, which were investigated through the use of the docking technique. A conventional dynamic simulation study lasting 20 ns was used to assess the interaction's stability. The parameters derived from the trajectories of molecular dynamic simulation were computed and validated with respect to the stability of the protein-ligand complex under dynamic conditions. The absorption-distribution-metabolism-excretion (ADME) values are favourable for all of the synthesized compounds . After testing each novel compound for in vitro anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv (ATCC27294), the most promising lead analogues were 9e (MIC: 1.56 μg/mL), 13b (MIC: 3.125 μg/mL), and 13e (MIC: 3.125 μg/mL). In this study, we have designed and produced new 5-substituted Oxindole derivatives as anti-tubercular drugs through the application of docking and molecular dynamic modeling. Given the increasing demand for novel antibiotics and the ensuing urgent need for novel anti-TB medications, we think the currently reported oxindole derivatives of DprE1 inhibitors present an excellent possibility for future optimization.

chemistry, physical
Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Santosh Kumar Sahoo,Mohammad Naiyaz Ahmad,Grace Kaul,Srinivas Nanduri,Arunava Dasgupta,Sidharth Chopra,Venkata Madhavi Yaddanapudi,santosh kumar sahoo

DOI: https://doi.org/10.1002/cbdv.202200324

2022-06-04

Abstract:In pursuit of potent anti‐TB agents active against drug resistant tuberculosis (DR‐TB), herein we report synthesis and bio‐evaluation of a new series of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives. Preliminary evaluation indicated selectivity towards Mtb H37Rv, with no inhibition of non‐tubercular mycobacterial (NTM) & bacterial pathogen panel. Out of 36 synthesized compounds, majority exhibited substantial inhibition of Mtb H37Rv (MIC 0.5‐8 μg/mL). Cell viability test against Vero cells revealed no significant cytotoxicity. Further, screening against drug resistant strains (DR‐Mtb) found hit compound displaying promising potency (MIC 1‐4 μg/mL). Structure optimization of the hit led to the identification of lead compound demonstrating potent inhibition of both drug‐susceptible Mtb (MIC 0.12 μg/mL) and drug‐resistant Mtb (MIC 0.25‐0.5 μg/mL) along with a high selectivity index (SI) >80. Taken together, with appreciable selectivity and potent activity, these chemotypes show prospect to be turned into a potential anti‐TB candidate.

chemistry, multidisciplinary,biochemistry & molecular biology
Design, Synthesis, Molecular Docking, Antitubercular, Antimicrobial and Antioxidant Studies of Some Novel 3-(((1H-Benzo[d]imidazol-2- yl)methyl)thio)-5H-[1,2,4] Triazino[5,6-b]indole Derivatives

Sreelatha Kamera,Vishnu Kumar Sharma,Srivani M,Achaiah Garlapati,Vishnu K Sharma

DOI: https://doi.org/10.25004/ijpsdr.2023.150414

2023-08-25

International Journal of Pharmaceutical Sciences and Drug Research

Abstract:A series of novel 3-(((1H-benzo[d]imidazol-2-yl)methyl)thio)-5H-[1,2,4]triazino[5,6-b]indole derivatives (3a-3j) were synthesized by reacting different substituted 5H-[1,2,4]triazino[5,6-b]indole-3-thiols with substituted (2-chloromethyl)-1H-benzo(d)imidazoles in the presence of KOH and water in good yields. The structures of the newly synthesized compounds were confirmed by spectroscopic techniques such as 1H-NMR, 13C-NMR, IR and mass spectrometry. The in-vitro antitubercular activity of the synthesized compounds was evaluated against Mycobacterium tuberculosis (Mtb) H37Rv (ATCC 27294) using MABA (Microplate Alamar Blue Assay) method. Compounds 3b, 3c, and 3i showed good antitubercular activity against Mtb with MIC value of 6.25 ± 0.00 μg/mL. Also, the in-vitro antimicrobial activities of the compounds were evaluated against various bacterial and fungal strains using the two-fold serial dilution technique and most of the compounds exhibited moderate activities with MIC values in the range of 63.33 ± 1.44 to >500 ????g/mL against the tested microorganisms. The compounds (3a-3j) were also tested for their in-vitro antioxidant activities by DPPH radical scavenging activity method and among the series, compounds 3e, 3a, and 3g exhibited strong antioxidant activity with IC50 values of 10.85 ± 0.05, 12.18 ± 0.13 and 12.57 ± 0.17????g/mL respectively compared to the standard ascorbic acid (IC50 value, 5.85 ± 0.04 ????g/mL). Further, molecular docking studies were performed to investigate the binding affinities as well as the interaction of these compounds with Mtb InhA target protein. In-silico ADME predictions showed that all the synthesized compounds have drug-like properties and exhibited good oral bioavailability.
New triazole based oxadiazolo/thiadiazolo–phthalazines as potent antimycobacterial agents: Design, synthesis, molecular modelling and in silico ADMET profiles

Anjanareddy Basava Reddy,Vidya Sagar Reddy Avuthu,Pilli VVN Kishore,Tejeswara Rao Allaka,Honnappa Nagarajaiah

DOI: https://doi.org/10.1002/slct.202304020

2024-01-05

ChemistrySelect

Abstract:A series of substituted phthalazine derivatives have been synthesized from the key intermediate mercapto‐containing oxadiazo‐phthalazinone. Among the prepared derivatives, 4‐methyl‐2‐((5‐(((1‐(4‐nitrobenzyl)‐1H‐1,2,3‐triazol‐5‐yl)methyl)thio)‐1,3,4‐oxadiazol‐2‐yl) methyl)phthalazin‐1(2H)‐one (5f) and 4‐methyl‐2‐((6‐(3‐nitrophenyl)‐[1,2,4]triazolo[3,4‐b][1,3,4]thiadiazol‐3‐yl)methyl) phthalazin‐1(2H)‐one (7a) have shown remarkable antitubercular activity against M. tuberculosis H37RV. Further, the physicochemical and medicinal properties have been evaluated using SwissADME and ADMETlab2.0 web server as good oral bioavailability drugs. The study of the chemical and biological properties of molecules simultaneously comprising various heterocycles, such as fused 1,3,4–oxadiazolyl–1,2,3–triazoles and 1,2,4–triazolyl–1,3,4–thiadiazole have been conducted as part of our ongoing research in the field of medicinal and organic chemistry. In this study, we performed ligand–based pharmacophore modelling as a promising design strategy of substituted phthalazinone derivatives (5 and 7). These were synthesized from key intermediate mercapto‐containing oxadiazo‐phthalazinone derivative 2. The synthesized compounds were characterized by IR, 1H and 13C NMR, elemental analysis and mass spectrometric techniques. In preliminary antibacterial studies, analogues 5 d, 5 f, 7 a and 7 d were found to be most effective against S. epidermidis, whereas 5 d displayed excellent activity against P. aeruginosa microorganism. Later, explored the probable key active site and inhibitors of Cytochrome P450 CYP121A1 interactions from M. tuberculosis H37Rv based antitubercular drug candidate with 5O4K protein and ligand 7 b possesses highest hydrophobic amino acid residues. The physicochemical and medicinal properties were also evaluated using SwissADME and ADMETlab2.0 web to function as effective oral bioavailability medications.

chemistry, multidisciplinary
Synthesis, Biological Evaluation, and Molecular Docking Study of Novel 5‐Substituted 1,2,4‐Oxadiazole‐3‐yl Benzoxazole Derivatives as Potential Antimicrobial Agents

Sandip Gadakh,Dhaval Prajapati,Balasaheb Aghav

DOI: https://doi.org/10.1002/slct.202404051

2024-11-07

ChemistrySelect

Abstract:We have developed an efficient divergent strategy to access various functionalized 5‐substituted 1,2,4‐oxadiazole‐3‐yl benzoxazole derivatives in good to excellent yields by one pot reaction involving nucleophilic addition reaction of amidoxime with aryl or alkyl acid chloride, followed by cyclodehydration in presence of base. A wide range of functional groups were tolerated during this process. Discovery of novel antimicrobial drugs is one of the hottest topics in the field of medicinal chemistry. An efficient and catalyst free synthesis of novel fluorinated 5‐substituted 1,2,4‐oxadiazole‐3‐yl benzoxazole derivatives is described. A series of novel compounds have been synthesized and characterized by different spectroscopic techniques such as FTIR, 1H NMR, 13C NMR, and LCMS. When tested for antibacterial activity, the synthesized benzoxazole derivatives exhibited outstanding to good activities in comparison to the conventional medications. Moreover, the theoretical forecasts grounded in molecular docking against microbial DNA gyrase may offer a glimpse into the conceivable mode of operation and establish a connection between the detected antimicrobial efficacy and the binding affinity, illuminating particular thermodynamic (bonded and nonbonded) interactions that regulate the activity. The produced compounds also exhibited promising qualities to develop into viable oral medication candidates when their absorption, distribution, metabolism, and excretion were examined. In summary, the research proposes that these novel compounds have emerged as interesting contender for the development of next generation antimicrobial drugs. Our protocol demonstrates broad substrate scope, dramatic decrease of synthesis time, and energy consumption with excellent yields.

chemistry, multidisciplinary
New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling

Asmaa F Kassem,Ahmed Sabt,Małgorzata Korycka-Machala,Moataz A Shaldam,Malwina Kawka,Bożena Dziadek,Magdalena Kuzioła,Jarosław Dziadek,Rasha Z Batran

DOI: https://doi.org/10.1016/j.bioorg.2024.107511

Abstract:Tuberculosis is a global serious problem that imposes major health, economic and social challenges worldwide. The search for new antitubercular drugs is extremely important which could be achieved via inhibition of different druggable targets. Mycobacterium tuberculosis enoyl acyl carrier protein reductase (InhA) enzyme is essential for the survival of M. tuberculosis. In this investigation, a series of coumarin based thiazole derivatives was synthesized relying on a molecular hybridization approach and was assessed against thewild typeMtb H37Rv and its mutant strain (ΔkatG) via inhibiting InhA enzyme. Among the synthesized derivatives, compounds 2b, 3i and 3j were the most potent against wild type M. tuberculosis with MIC values ranging from 6 to 8 μg/ mL and displayed low cytotoxicity towards mouse fibroblasts at concentrations 8-13 times higher than the MIC values. The three hybrids could also inhibit the growth of ΔkatGmutant strain which is resistant to isoniazid (INH). Compounds 2b and 3j were able to inhibit the growth of mycobacteria inside human macrophages, indicating their ability to penetrate human professional phagocytes. The two derivatives significantly suppress mycobacterial biofilm formation by 10-15 %. The promising target compounds were also assessed for their inhibitory effect against InhA and showed potent effectiveness with IC50 values of 0.737 and 1.494 µM, respectively. Molecular docking studies revealed that the tested compounds occupied the active site of InhA in contact with the NAD+ molecule. The 4-phenylcoumarin aromatic system showed binding interactions within the hydrophobic pocket of the active site. Furthermore, H-bond formation and π -π stacking interactions were also recorded for the promising derivatives.
Chemical synthesis and molecular modeling of novel substituted N-1,3-benzoxazol-2yl benzene sulfonamides as inhibitors of inhA enzyme and Mycobacterium tuberculosis growth

Narendra Singh Chundawat,Gajanan S. Shanbhag,Narendra Pal Singh Chauhan

DOI: https://doi.org/10.1007/s13738-020-02080-0

2020-10-27

Journal of the Iranian Chemical Society

Abstract:Tuberculosis (TB) is one of the major contagious diseases with high mortality which is caused by Mycobacterium tuberculosis (Mtb) pathogen. Due to the existing antibiotic resistance (MDR-TB) to tuberculosis, the demand for the development of new potential chemotherapy drugs is increasing. Herein, we report synthesis of two novel benzoxazole-based series, namely 2-phenyl benzoxazole sulfonamide and 2-piperidine-benzoxazole sulfonamides. These compounds were evaluated for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv strain, using the microplate alamarBlue assay. Molecular docking studies were carried out to comprehend the binding mode of the compounds. It is evident from molecular docking studies and minimum inhibitory concentration assay (MIC) that 2-phenyl benzoxazole sulfonamide scaffold has a greater potential of antitubercular activity possibly by ENR inhibition (inhA inhibitors). In silico cytotoxicity studies using CLC-Pred tool database suggested that both the series were relatively safe.

chemistry, multidisciplinary
Synthesis, In Vitro and In Silico Evaluation of 3-(4, 5-Diphenyl-4H-1,2,4-triazol-3-yl)pyridine Derivatives As Potential Antimicrobial Agents

Sharma, S.

DOI: https://doi.org/10.1134/s1068162024050169

2024-10-10

Russian Journal of Bioorganic Chemistry

Abstract:Objective: The objective of the present work was to synthesized, purify, characterize and evaluate the antibacterial, antifungal, and antitubercular activity of some substituted triazoles. Several variants of 3-(4,5diphenyl-4 H -1,2,4-triazol-3-yl)pyridine ( A1–A9 ) were synthesized. Methods: Observations were made in differentiation with the reference drug, Griseofulvin (200 μg/mL). The encouraging results from the antibacterial studies impelled us to go for preliminary screening of synthesized compounds against M. tuberculosis H37Rv were performed by LJ agar (MIC) method. Results and Discussion: All of the prepared analogues were tested for their antibacterial efficacy against the pathogenic germs S. aureus and E. coli (Gram-negative) using Norfloxacin (200 μg/mL) as standard. Conclusions: Compounds ( A2 ) and ( A4 ) derivatives showed better antibacterial activity as compared to other derivatives towards both Gram-negative and Gram-positive bacterial strain. Compounds ( A1 ), ( A3 ), and ( A5 ) were also retained good antibacterial activity. All scaffolds have promising antibacterial activity because of electron donor groups such as hydroxy and phenyl. Similarly ( A1 ), ( A3 ), and ( A7 ) have shown significant and better antimycotic activity against Aspergillus niger and Candida albicans. On the basis of preceding evaluation of the antitubercular activity revealed, following observations were made in comparison to the standard drug streptomycin, the derivatives ( A1 ), ( A3 ), and ( A6 ) have shown promising and better result as compared to the other derivatives. Derivative ( A4 ) represented considerable binding with InhA, the enoyl acyl carrier protein reductase (PDB ID: 2X22) from Mycobacterium tuberculosis as denoted by stable molecular dynamics of 100 ns.

biochemistry & molecular biology,chemistry, organic
Synthesis, In Vitro Antimycobacterial Activity of Some 2-((5-Amino-1,3,4-Thiadiazol-2-YL)Methyl)-6-Aryl-Tetrahydropyridazin-3-One Derivatives

Asif, Mohammad

DOI: https://doi.org/10.1007/s11094-024-03203-0

2024-09-20

Pharmaceutical Chemistry Journal

Abstract:A series of 2-((5-amino-1,3,4-thiadiazol-2-yl)methyl)-6-aryl-2,3,4,5-tetrahydro-pyridazin-3-one ( 4a-e ) was synthesized and evaluated for its in vitro antimycobacterial activity. All the synthesized compounds were structurally confirmed by using physicochemical and spectral analysis such as melting point, R f value, elemental analysis, IR, NMR and mass spectra. In vitro antimycobacterial activity was screened by the microplate Alamar Blue Assay (MABA) method against Mycobacterium tuberculosis H37Rv strain. Derivatives with 4-ethyl phenyl substitution ( 4b ) and chloro phenyl substitution ( 4e ) at the p -position of pyridazinone nuclei showed good antimycobacterial activity with a MIC value of 6.25 μg/ml compared to other aryl substitutions such as 4-methoxy phenyl ( 4a ), 4-methyl phenyl ( 4c ) with a MIC value of 25 and 12.5 μg/ml. The results of in vitro antimycobacterial activity revealed that the synthesized compounds have potential antimycobacterial action and can be further optimized and developed as lead compounds.

pharmacology & pharmacy,chemistry, medicinal
Design, Synthesis, in Vitro, and in Silico Evaluations of 1,3,4‐Oxadiazole Derivatives Linked to the Pyrrolo[2,3‐d]pyrimidine Moieties as Potent Antimicrobial Targets

Jeevan Lal Patel,Naveen Kumar Sureddy,Murali Boddupalli,Raju Chedupaka,Venkatesham Papisetti,Mahapatra S. P.,Santhosh Penta

DOI: https://doi.org/10.1002/slct.202400117

2024-06-20

ChemistrySelect

Abstract:Novel 1,3,4‐oxadiazole derivatives linked to pyrrolo[2,3‐d]pyrimidine are synthesized and evaluated for their in‐vitro antibacterial and antifungal activities. Compounds 6 d, 6 e, 6 f, and 7e exhibit potent antimicrobial activity, while compounds 6 f and 7 a demonstrate excellent antifungal activity. Additionally, docking studies highlight key binding interactions with the Staphylococcus aureus DHFR enzyme. The most effective inhibitors, compounds 6 and 7, also undergo in‐silico ADMET tests to predict their pharmacokinetic and physicochemical characteristics. 1,3,4‐Oxadiazole and its derivatives are well known assorted motif in drug design and development. The development of bacterial infection drug resistance serves as justification for the discovery of novel antimicrobial drugs. Thus, a novel series of 1,3,4‐oxadiazole derivatives linked to pyrrolo[2,3‐d]pyrimidine 6 a–f and 7 a–e was designed, synthesized and fully characterized by 1H‐NMR, 13C‐NMR, FT‐IR and mass spectroscopic analysis. All of the compounds′ in‐vitro antibacterial and antifungal activities were reported, and final oxadiazoles 6 d, 6 e, 6 f, and 7 e showed excellent antimicrobial inhibitory activity as compared to standard drugs. The compounds 6 f and 7 a exhibited potent antifungal activity as a potent inhibitor against C. albicans with MICs 4.0±0.03, 7.5±0.02 μg/mL respectively. In order to determine the different binding interactions that the most active oxadiazoles had with the Staphylococcus aureus DHFR enzyme, a docking study was conducted. The results indicated that the residues of amino acid Thr96(X), Leu62(X), Arg44(X), Asn18(X), Glu17(X), Lys45(X), Thr121(X), Gln95(X), Asp120(X), Ser64(X), Gly94(X), and Phe16(X) had promising energy value, within the range of −6.84 to −9.63 kcal/mol (PDB: 3FRA). The most effective inhibitors, 6 and 7, also underwent in silico ADMET tests to predict their pharmacokinetic and physicochemical characteristics.

chemistry, multidisciplinary
Design, Synthesis, Evaluation of Antitubercular Activity and Insilco Studies of Novel 1,5‐Naphthyridin‐2(1H)‐one Pendent 1,2,3‐Triazoles

Nagendra Babu Chilakala,Arnab Roy,Nitin Pal Kalia,Vishnu Thumma,Raju B,Sharada Etnoori,Premalatha K

DOI: https://doi.org/10.1002/cbdv.202401491

2024-08-24

Chemistry & Biodiversity

Abstract:A library of 1,5‐Naphthyridin‐2(1H)‐one based 1,2,3‐triazole analogues (11a‐q) were synthesized via series of reactions such as protection, oxidation, cyclization and click chemistry. The new molecules were tested for their antitubercular activity against M. tuberculosis mc26230 and determined the minimum inhibitory concentration (MIC90) employing Rifampicin as reference. The 3‐cyano and 4‐cyano substituted analogues 11e and 11f displayed superior activity with an MIC value of 4.0 μg/ml. Additionally, these potent molecules were tested for determination of their MBC values and ATP depletion assay showed a hopeful relative luminescence. Additionally, determined the MIC of 11e and 11f against multi‐drug resistant strains of M. Tuberculosis viz.mc2 8243, mc2 8247 and mc2 8259. The cytotoxicity of these two molecules presented no effects on normal cell. The profound results of these two molecules proved them as potential antitubercular agent. Further, molecular docking studies were portrayed against crystal structure of M. Tuberculosis dihydrofolate reductase which garnered promising docking scores and binding interactions such as H‐bond and hydrophobic. ADME prediction revealed their favorable drug‐likeness characteristics.

chemistry, multidisciplinary,biochemistry & molecular biology
Synthesis and Anti-Mycobacterium Activity of Some New N-Rich Heterocyclic Derivatives and Their Molecular Docking, and DFT Studies

Raghavendra Hegde,Itte Pushpavathi,Talavara Venkatesh,O. Nagaraja,S. Ravi Kumar

DOI: https://doi.org/10.1134/s1068162024010199

2024-02-14

Russian Journal of Bioorganic Chemistry

Abstract:Objective: Synthesis of N -rich heterocyclic derivatives; anti-TB activity, molecular docking, ADME-T, and computational studies. Methods: Synthesis was carried out by conventional method; structures of synthesised was confirmed by different spectroscopic methods; evaluation of anti-TB activity was done by Microplate Alamar Blue assay (MABA); Molecular docking was analyzed by using ChemBioDraw tool (part of the ChemBioOffice Ultra 14.0 suite) and ADME was done by web programme Swiss ADME; DFT studies was carried out by DFT (B3LYP) with the aid of the 6-311++G(d,p) basis set in the Gaussian 09 software. Results: The activity results showed that compounds ( IIIc ) and ( IIIe ) demonstrated outstanding activity with MIC values of 1.6 μg/mL, which are closer to the reference standards of rifampicin and streptomycin, while the remaining compounds had reduced efficacy. Discussion: These results show that activity affected by the pyrimidine core and indole moiety of ( IIIc ) and ( IIIe ) showed very effective efficacy compared to the reference standards, respectively. Conclusions: Based on the anti-TB activity findings, in-silico molecular docking and ADME profiles, our synthesized drugs followed all five criteria, including high GI absorption, no blood-brain barrier, and minimal skin permeability. Compounds ( IIIa ) and ( IIIb ) demonstrated a smaller energy gap in the DFT analysis, indicating that it is chemically more reactive than other compounds. As a result, these compounds demonstrated increased anti-TB activity.

biochemistry & molecular biology,chemistry, organic
Design, synthesis, anti-tubercular activity, and computational studies of novel 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one derivatives

Neeru Bhanwala,Niranjana Sri Sundaramoorthy,Sirisha Gollapudi,Anita Sharma,Ramandeep Singh,Gopal L. Khatik

DOI: https://doi.org/10.1007/s00044-024-03295-z

2024-09-11

Medicinal Chemistry Research

Abstract:Tuberculosis (TB) is a contagious disease caused by M. tuberculosis ( Mtb ) affecting people across the globe. Quinoline and chalcone cores have good anti-tubercular properties; thus, we have designed a hybrid scaffold containing quinoline and chalcone. A series of 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one analogs 7a-p and 8a-k were synthesized through different reactions involving nucleophilic substitution, Vilsmeier Haack formylation, Claisen Schmidt condensation, and demethylation. Spectroscopic methods, including 1 H NMR, 13 C NMR, IR, and HRMS, were used to characterize all synthesized compounds. The anti-tubercular activity of compounds 7a-p and 8a-k was assessed against Mtb H 37 Rv (ATCC 27294). These compounds demonstrated anti-tubercular activity against H 37 Rv in the range of 6.25–50 μM. Swiss ADME's in silico computational studies showed that the ADME parameters were better and had a good pharmacokinetic profile. The compounds 8a, 7a , and 7p showed the most potential as anti-TB activity against Mtb H37Rv in this study, with MIC values of 6.25 μM, 12.5 μM, and 10 μM, respectively.

chemistry, medicinal
Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents

Apeng Wang,Shijie Xu,Yun Chai,Guimin Xia,Bin Wang,Kai Lv,Dan Wang,Xiaoyu Qin,Bin Jiang,Wenhao Wu,Mingliang Liu,Yu Lu

DOI: https://doi.org/10.1016/j.bmc.2021.116529

2022-01-01

Abstract:Three series of novel nitrofuran-1,3,4-oxadiazole hybrids were designed and synthesized as new anti-TB agents. The structure activity relationship study indicated that the linkers and the substituents on the oxadiazole moiety greatly influence the activity, and the substituted benzenes are more favoured than the cycloalkyl or heterocyclic groups. Besides, the optimal compound in series 2 was active against both MTB H37Rv strain and MDR-MTB 16883 clinical isolate and also displayed low cytotoxicity, low inhibition of hERG and good oral PK, indicating its promising potential to be a lead for further structural modifications.

biochemistry & molecular biology,chemistry, medicinal, organic
Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole

Smriti Srivastava,Devla Bimal,Kapil Bohra,Balram Singh,Prija Ponnan,Ruchi Jain,Mandira Varma-Basil,Jyotirmoy Maity,M Thirumal,Ashok K Prasad

DOI: https://doi.org/10.1016/j.ejmech.2018.02.067

2018-04-25

Abstract:A series of β-d-ribofuranosyl coumarinyl-1,2,3-triazoles have been synthesized by Cu-catalyzed cycloaddition reaction between azidosugar and 7-O-/7-alkynylated coumarins in 62-70% overall yields. The in vitro antimycobacterial activity evaluation of the synthesized triazolo-conjugates against Mycobacterium tuberculosis revealed that compounds were bactericidal in nature and some of them were found to be more active than one of the first line antimycobacterial drug ethambutol against sensitive reference strain H37Rv, and 7 to 420 times more active than all four first line antimycobacterial drugs (isoniazid, rifampicin, ethambutol and streptomycin) against multidrug resistant clinical isolate 591. Study of in silico pharmacokinetic profile indicated the drug like characters for the test molecules. Further, transmission electron microscopic experiments revealed that these compounds interfere with the constitution of bacterial cell wall possibly by targeting mycobacterial InhA and DNA gyrase enzymes. Study conducted on the activities of the test compounds on bacterial InhA and DNA gyrase revealed that the most bactericidal test compound, N1-(β-d-ribofuranosyl)-C4-(4-methylcoumarin-7-oxymethyl)-1,2,3-triazole (6b) and its corresponding directly linked conjugate N1-(β-d-ribofuranosyl)-C4-(4-methylcoumarin-7-yl)-1,2,3-triazole (11b) significantly inhibited the activity of both the enzymes. The results were further supported by molecular docking studies of the compound 6b and 11b with bacterial InhA and DNA gyrase B enzymes. Further, the cytotoxicity study of some of the better active compounds on THP-1 macrophage cell line using MTT assay showed that the synthesized compounds were non-cytotoxic.
Design, Synthesis, Antibacterial and Antitubercular Studies of Some New Benzimidazoles. A Combined Experimental and Computational Approach

Tushar Ranjan Mohapatra,Swastika Ganguly

DOI: https://doi.org/10.1002/slct.202304791

2024-03-20

ChemistrySelect

Abstract:This study outlines the development, synthesis, characterization, and evaluation of the antibacterial and antimycobacterial properties of seventeen derivatives of 2‐(4‐chlorophenyl)‐1H‐benzo[d]imidazole‐N‐aryl acetamides 3(a–q). Among these synthesized compounds, compound 3 m demonstrated the most potent antibacterial activity, while compound 3 k exhibited the highest antimycobacterial activity. Molecular docking studies confirmed their significant binding affinity to Glucosamine‐6‐phosphate synthase and the active site of Mycobacterium tuberculosis. A novel series of seventeen 2‐(4‐chlorophenyl)‐1H‐benzo[d]imidazole‐N‐aryl acetamides derivatives 3(a–q) were synthesized by nucleophilic substitution of 2‐chloro‐N‐(aryl)‐acetamides 2(a–q) with 2‐(4‐chlorophenyl)‐1H‐benzo[d]imidazole (1) in N,N‐Dimethylformamide. The literature indicates that the primary compound, 2‐(4‐chlorophenyl)‐1H‐benzo[d]imidazole (1), not only serves as a synthetic precursor but also exhibit anthelmintic, antiviral, and antifungal activities. The synthesized compounds were estimated for their structures through elemental analysis and spectral data examination. All the compounds be subjected to evaluation for their antibacterial activity against Bacillus subtilis (NCIM 2920), Staphylococcus aureus (NCIM 2901), Escherichia coli (NCIM 2810), Pseudomonas aeruginosa (NCIM 5223), and antimycobacterial activity against Mycobacterium smegmatis (ATCC607). Compound 3 m, exhibit the highest antibacterial activity with a MIC value of 1.562 μg/ml against all tested bacterial strains and compound 3 k, exhibited the highest antimycobacterial activity with a MIC value of 3.96 μg/ml. Additionally, we performed docking investigations of the most active compounds within the active binding site of the co‐crystallized structure of Glucosamine‐6‐phosphate synthase (PDB ID: 2VF5) and Mycobacterium tuberculosis (PDB ID: 2X22).

chemistry, multidisciplinary

Interpretation of the Hydrogen and Helium Spectra.

Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation

Design, synthesis, characterization, and biological evaluation of novel pyrazine-1,3,4-oxadiazole/[1,2,4] triazolo[3,4-b][1,3,4]thiadiazine hybrids as potent antimycobacterial agents

In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis

Synthesis, Characterization, Antimicrobial, Anti-tubercular, Antioxidant Activities and Docking Simulations of Derivatives of 2-(pyridin-3-yl)-1Hbenzo[ d]imidazole and 1,3,4-Oxadiazole Analogy

Development and Evaluation of New Oxindole Derivatives as Potential Anti-tubercular Agents

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Design, Synthesis, Molecular Docking, Antitubercular, Antimicrobial and Antioxidant Studies of Some Novel 3-(((1H-Benzo[d]imidazol-2- yl)methyl)thio)-5H-[1,2,4] Triazino[5,6-b]indole Derivatives

New triazole based oxadiazolo/thiadiazolo–phthalazines as potent antimycobacterial agents: Design, synthesis, molecular modelling and in silico ADMET profiles

Synthesis, Biological Evaluation, and Molecular Docking Study of Novel 5‐Substituted 1,2,4‐Oxadiazole‐3‐yl Benzoxazole Derivatives as Potential Antimicrobial Agents

New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling

Chemical synthesis and molecular modeling of novel substituted N-1,3-benzoxazol-2yl benzene sulfonamides as inhibitors of inhA enzyme and Mycobacterium tuberculosis growth

Synthesis, In Vitro and In Silico Evaluation of 3-(4, 5-Diphenyl-4H-1,2,4-triazol-3-yl)pyridine Derivatives As Potential Antimicrobial Agents

Synthesis, In Vitro Antimycobacterial Activity of Some 2-((5-Amino-1,3,4-Thiadiazol-2-YL)Methyl)-6-Aryl-Tetrahydropyridazin-3-One Derivatives

Design, Synthesis, in Vitro, and in Silico Evaluations of 1,3,4‐Oxadiazole Derivatives Linked to the Pyrrolo[2,3‐d]pyrimidine Moieties as Potent Antimicrobial Targets

Design, Synthesis, Evaluation of Antitubercular Activity and Insilco Studies of Novel 1,5‐Naphthyridin‐2(1H)‐one Pendent 1,2,3‐Triazoles

Synthesis and Anti-Mycobacterium Activity of Some New N-Rich Heterocyclic Derivatives and Their Molecular Docking, and DFT Studies

Design, synthesis, anti-tubercular activity, and computational studies of novel 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one derivatives

Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents

Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole

Design, Synthesis, Antibacterial and Antitubercular Studies of Some New Benzimidazoles. A Combined Experimental and Computational Approach